HEG1 - Revision history

Michael at 15:56, 15 September 2025

2025-09-15T15:56:17Z

← Older revision		Revision as of 15:56, 15 September 2025
Line 1:		Line 1:
	'''HEG1''' is an [[immunostain]] ~~positive~~ in [[malignant mesothelioma]].<ref name=pmid28361969>{{cite journal \|authors=Tsuji S, Washimi K, Kageyama T, Yamashita M, Yoshihara M, Matsuura R, Yokose T, Kameda Y, Hayashi H, Morohoshi T, Tsuura Y, Yusa T, Sato T, Togayachi A, Narimatsu H, Nagasaki T, Nakamoto K, Moriwaki Y, Misawa H, Hiroshima K, Miyagi Y, Imai K \|title=HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma \|journal=Sci Rep \|volume=7 \|issue= \|pages=45768 \|date=March 2017 \|pmid=28361969 \|doi=10.1038/srep45768 \|url=}}</ref>		'''HEG1''' is an [[immunostain]] used in the diagnosis of [[malignant mesothelioma]].<ref name=pmid28361969>{{cite journal \|authors=Tsuji S, Washimi K, Kageyama T, Yamashita M, Yoshihara M, Matsuura R, Yokose T, Kameda Y, Hayashi H, Morohoshi T, Tsuura Y, Yusa T, Sato T, Togayachi A, Narimatsu H, Nagasaki T, Nakamoto K, Moriwaki Y, Misawa H, Hiroshima K, Miyagi Y, Imai K \|title=HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma \|journal=Sci Rep \|volume=7 \|issue= \|pages=45768 \|date=March 2017 \|pmid=28361969 \|doi=10.1038/srep45768 \|url=}}</ref>

	==Use==		==Use==

Michael at 15:55, 15 September 2025

2025-09-15T15:55:51Z

← Older revision		Revision as of 15:55, 15 September 2025
Line 1:		Line 1:
	'''HEG1''' is an [[immunostain]] positive in [[malignant mesothelioma]].<ref name=pmid28361969>{{cite journal \|authors=Tsuji S, Washimi K, Kageyama T, Yamashita M, Yoshihara M, Matsuura R, Yokose T, Kameda Y, Hayashi H, Morohoshi T, Tsuura Y, Yusa T, Sato T, Togayachi A, Narimatsu H, Nagasaki T, Nakamoto K, Moriwaki Y, Misawa H, Hiroshima K, Miyagi Y, Imai K \|title=HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma \|journal=Sci Rep \|volume=7 \|issue= \|pages=45768 \|date=March 2017 \|pmid=28361969 \|doi=10.1038/srep45768 \|url=}}</ref>		'''HEG1''' is an [[immunostain]] positive in [[malignant mesothelioma]].<ref name=pmid28361969>{{cite journal \|authors=Tsuji S, Washimi K, Kageyama T, Yamashita M, Yoshihara M, Matsuura R, Yokose T, Kameda Y, Hayashi H, Morohoshi T, Tsuura Y, Yusa T, Sato T, Togayachi A, Narimatsu H, Nagasaki T, Nakamoto K, Moriwaki Y, Misawa H, Hiroshima K, Miyagi Y, Imai K \|title=HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma \|journal=Sci Rep \|volume=7 \|issue= \|pages=45768 \|date=March 2017 \|pmid=28361969 \|doi=10.1038/srep45768 \|url=}}</ref>

			==Use==
			*Positive in [[malignant mesothelioma]], especially epithelioid type.<ref>{{cite journal \|authors=Naso JR, Tsuji S, Churg A \|title=HEG1 Is a Highly Specific and Sensitive Marker of Epithelioid Malignant Mesothelioma \|journal=Am J Surg Pathol \|volume=44 \|issue=8 \|pages=1143–1148 \|date=August 2020 \|pmid=32205484 \|doi=10.1097/PAS.0000000000001469 \|url=}}</ref>

	==See also==		==See also==
	*[[Claudin-4]].		*[[Claudin-4]].
			*[[BAP1]].

	==References==		==References==

Michael: create

2025-09-15T14:49:17Z

create

New page

'''HEG1''' is an [[immunostain]] positive in [[malignant mesothelioma]].<ref name=pmid28361969>{{cite journal |authors=Tsuji S, Washimi K, Kageyama T, Yamashita M, Yoshihara M, Matsuura R, Yokose T, Kameda Y, Hayashi H, Morohoshi T, Tsuura Y, Yusa T, Sato T, Togayachi A, Narimatsu H, Nagasaki T, Nakamoto K, Moriwaki Y, Misawa H, Hiroshima K, Miyagi Y, Imai K |title=HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma |journal=Sci Rep |volume=7 |issue= |pages=45768 |date=March 2017 |pmid=28361969 |doi=10.1038/srep45768 |url=}}</ref>

==See also==
*[[Claudin-4]].

==References==
{{Reflist|1}}

[[Category:Immunohistochemistry]]